Related Experiment Video
Updated: Feb 7, 2026
07:16
Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
1.8K
Recent advances in developing therapeutics for cystic fibrosis
Lisa J Strug1,2,3, Anne L Stephenson4,5, Naim Panjwani3
1Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Human Molecular Genetics
|July 31, 2018
Summary
Cystic Fibrosis (CF) treatments are advancing rapidly, moving beyond symptom management to focus on genetic and biochemical cures. New therapies aim to correct the defective CFTR protein or address the underlying genetic cause, offering hope for a broadly treatable disease.
Area of Science:
- Genetics and Molecular Biology
- Pharmacology
- Physiology
Background:
- Cystic Fibrosis (CF) affects over 70,000 people globally, remaining a life-shortening illness despite gene discovery.
- The approval of Ivacaftor, a CFTR protein corrector, marked a significant therapeutic advancement for specific CF mutations.
Purpose of the Study:
- To review recent progress in CF research focusing on genetic, biochemical, and physiological correction strategies.
- To highlight the development of mutation-specific therapies due to the complexity of over 2000 CFTR variants.
- To explore emerging therapeutic approaches for treating Cystic Fibrosis.
Main Methods:
- Review of novel drug combinations enhancing CFTR protein delivery and function.
- Analysis of genetic therapies including stop mutation repression, splice modulation, gene editing, and gene replacement.
- Exploration of modifier genes to restore normal CF phenotype.
Main Results:
- Significant progress has been made across diverse research areas targeting CF.
- Development of drugs that enhance the delivery or function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein.
- Advancements in genetic correction strategies offer potential for treating various CFTR mutations.
Conclusions:
- The development of mutation-specific therapies is likely the future focus for CF treatment.
- Emerging genetic and biochemical approaches hold promise for a broadly treatable CF.
- Dramatic progress suggests CF may soon become a broadly manageable disease.
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
888
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
888
01:24Cystic Fibrosis: Management
545
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
545
01:13Therapeutic Index
6.9K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K
02:22Overview of Advanced Functional Groups
30.1K
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
30.1K
00:56Extraction: Advanced Methods
1.2K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.2K
01:30Therapeutic Communication
8.5K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.5K